SCHEMBL7405175

SCHEMBL7405175

O=S(=O)(Cl)c1cc2c(cc1Cl)NC(CCc1ccccc1)NS2(=O)=O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.65
▸ CYP1A2 P05177 2/20 0.65
▸ L3MBTL1 Q9Y468 1/20 0.65
▸ TDP1 Q9NUW8 1/20 0.53
▸ LMNA P02545 4/20 0.48
▸ CYP3A4 P08684 4/20 0.48
▸ KDM4E B2RXH2 3/20 0.48
▸ CA2 P00918 2/20 0.48
▸ ABCB11 O95342 1/20 0.48
▸ SLC6A3 Q01959 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ CYP2C9 P11712 2/20 0.48
▸ ADRA2B P18089 1/20 0.48
▸ HPGD P15428 1/20 0.46
▸ ATM Q13315 1/20 0.46
▸ HTT P42858 1/20 0.43
▸ CA12 O43570 1/20 0.43
▸ CA1 P00915 1/20 0.43
▸ CA4 P22748 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7410862 0.82 TDP1 (0.63) ALDH1A1CYP1A2L3MBTL1TDP1LMNA
SCHEMBL7350074 0.81 TDP1 (0.62) ALDH1A1CYP1A2L3MBTL1TDP1LMNA
SCHEMBL18309810 0.79 ALDH1A1 (0.80) ALDH1A1CYP1A2L3MBTL1TDP1LMNA
Benzylhydrochlorothiazide SCHEMBL18314134 0.79 ALDH1A1 (1.00) ALDH1A1CYP1A2L3MBTL1TDP1LMNA
Benzylhydrochlorothiazide SCHEMBL49671 0.79 ALDH1A1 (1.00) ALDH1A1CYP1A2L3MBTL1TDP1LMNA
Hydrobentizide SCHEMBL564232 0.74 ALDH1A1 (0.76) ALDH1A1CYP1A2L3MBTL1TDP1LMNA
SCHEMBL14140882 0.72 TDP1 (0.60) ALDH1A1CYP1A2L3MBTL1TDP1LMNA
SCHEMBL13685990 0.71 TDP1 (0.58) ALDH1A1CYP1A2L3MBTL1TDP1LMNA
SCHEMBL13685906 0.70 TDP1 (0.69) ALDH1A1CYP1A2L3MBTL1TDP1LMNA
SCHEMBL11038368 0.69 TDP1 (0.77) ALDH1A1CYP1A2L3MBTL1TDP1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5015641-A Dipeptide for vision defects ANDREWS DAVID R (US) 1991-05-14 — — US disclosed
US-4885293-A CARBOXYALKYL DIPEPTIDES SCHERING CORPORATION (US) 1989-12-05 — — US disclosed
EP-0195817-B1 CARBOXYALKYLDIPEPTIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING CORPORATION (US) 1989-10-18 — — EP disclosed
US-4826816-A Antihypertensive compounds SCHERING CORPORATION (US) 1989-05-02 — — US disclosed
US-4634698-A TOPICAL HYPOTENSIVES SCHERING CORPORATION (US) 1987-01-06 — — US disclosed
EP-0195817-A1 CARBOXYALKYLDIPEPTIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. SCHERING CORP (US) 1986-10-01 — — EP disclosed
WO-1986001803-A1 CARBOXYALKYLDIPEPTIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING CORPORATION (US) 1986-03-27 — — WO disclosed
US-4556655-A TREATMENT OF CARDIOVASCULAR DISORDERS AND GLAUCOMA SCHERING CORPORATION (US) 1985-12-03 — — US disclosed
Send feedback